Ally Bridge Group as of June 30, 2021
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 29 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Medavail Holdings Ord | 8.9 | $36M | 2.9M | 12.25 | |
Spdr Ser Tr Put Put Option | 6.7 | $27M | 200k | 135.40 | |
Natera (NTRA) | 6.1 | $25M | 218k | 113.53 | |
Fate Therapeutics (FATE) | 5.8 | $23M | 270k | 86.79 | |
Apellis Pharmaceuticals Call Call Option | 4.7 | $19M | 300k | 63.20 | |
Syros Pharmaceuticals | 4.7 | $19M | 3.4M | 5.45 | |
Arvinas Ord (ARVN) | 4.6 | $19M | 240k | 77.00 | |
Cerevel Therapeutics Hldng I (CERE) | 4.3 | $17M | 676k | 25.62 | |
Repligen Corporation (RGEN) | 4.1 | $17M | 83k | 199.62 | |
Nuvation Bio Com Cl A (NUVB) | 4.0 | $16M | 1.7M | 9.31 | |
Miragen Therapeutics (VRDN) | 3.9 | $16M | 860k | 18.29 | |
Mirati Therapeutics | 3.8 | $15M | 95k | 161.53 | |
Nautilus Biotechnology (NAUT) | 3.8 | $15M | 1.5M | 10.10 | |
Intellia Therapeutics (NTLA) | 3.7 | $15M | 93k | 161.91 | |
Cyteir Therapeutics | 3.3 | $13M | 627k | 21.40 | |
Cogent Biosciences (COGT) | 3.3 | $13M | 1.6M | 8.11 | |
Nanostring Technologies (NSTGQ) | 3.0 | $12M | 185k | 64.79 | |
Ideaya Biosciences (IDYA) | 2.7 | $11M | 510k | 20.99 | |
Iovance Biotherapeutics (IOVA) | 2.6 | $11M | 407k | 26.02 | |
Essa Pharma Com New (EPIX) | 2.6 | $10M | 363k | 28.57 | |
Invitae (NVTAQ) | 2.5 | $10M | 300k | 33.73 | |
Gossamer Bio (GOSS) | 2.4 | $9.5M | 1.2M | 8.12 | |
Atea Pharmaceuticals (AVIR) | 2.0 | $8.0M | 373k | 21.48 | |
Bolt Biotherapeutics (BOLT) | 1.6 | $6.4M | 412k | 15.46 | |
Apellis Pharmaceuticals (APLS) | 1.3 | $5.4M | 85k | 63.20 | |
Adicet Bio (ACET) | 1.1 | $4.4M | 425k | 10.29 | |
Silverback Therapeutics (SPRY) | 1.0 | $4.0M | 129k | 30.89 | |
Freeline Therapeutics Hldgs Sponsored Ads | 0.8 | $3.3M | 402k | 8.15 | |
Macrogenics (MGNX) | 0.8 | $3.0M | 113k | 26.86 |